Adaptive Biotechnologies Corp (ADPT)
Data as of , from SEC Form 4 filings.
See up to 3 months of ADPT. The 7-day demo opens the 1M and 3M ranges and puts ADPT on your watchlist.
Start 7-day demoLatest ADPT insider trades
Julie Rubinstein - OfficerOpen-market sale$314K
About Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
- SEATTLE, WA
- 624
- 2019
- XNAS
https://www.adaptivebiotech.comSEC filings for ADPT on EDGAR
ADPT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 37 | 1,629,196 | $39.51M |
| Option exercise | 48 | 2,519,686 | |
| Bona-fide gift | 1 | 12,539 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ADPT insider transactions (Form 4)
15081 Form 4 filings on record, the earliest from Oct 10, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 11,881 | $26.41 footnote F2 | $314K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 9,181 | $25.35 footnote F3 | $233K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 2,700 | $26.07 footnote F4 | $70K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 11,881 | $25.50 footnote F5 | $303K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| ||||||
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 9,381 | $27.36 footnote F2 | $257K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 1,100 | $28.21 footnote F3 | $31K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 901 | $29.71 footnote F4 | $27K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 499 | $30.53 footnote F5 | $15K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 11,881 | $26.40 footnote F6 | $314K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 11,881 | $25.66 footnote F7 | $305K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| ||||||
| Susan Bobulsky - Officer | Open-market sale | Common Stock | 6,444 | $30.00 | $193K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 6,081 | $27.57 footnote F2 | $168K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 5,800 | $28.56 footnote F3 | $166K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 11,881 | $28.13 footnote F4 | $334K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 11,881 | $12.14 | $144K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 6,699 | $28.82 footnote F5 | $193K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 5,182 | $29.67 footnote F6 | $154K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 11,881 | $0.00 | - | |
| ||||||
| Francis Lo - Officer | Option exercise | Common Stock | 8,038 | $8.46 | $68K | |
| Francis Lo - Officer | Option exercise | Common Stock | 9,377 | $3.99 | $37K | |
| Francis Lo - Officer | Option exercise | Common Stock | 9,377 | $8.12 | $76K | |
| Francis Lo - Officer | Open-market sale | Common Stock | 8,094 | $27.52 footnote F2 | $223K | |
| Francis Lo - Officer | Open-market sale | Common Stock | 18,698 | $28.61 footnote F3 | $535K | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 8,038 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 9,377 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 9,377 | $0.00 | - | |
| ||||||
| Francis Lo - Officer | Option exercise | Common Stock | 53,091 | $12.14 | $645K | |
| Francis Lo - Officer | Option exercise | Common Stock | 13,398 | $8.46 | $113K | |
| Francis Lo - Officer | Option exercise | Common Stock | 15,629 | $3.99 | $62K | |
| Francis Lo - Officer | Option exercise | Common Stock | 23,442 | $8.12 | $190K | |
| Francis Lo - Officer | Open-market sale | Common Stock | 107,537 | $28.02 footnote F2 | $3.01M | |
| Francis Lo - Officer | Open-market sale | Common Stock | 7,869 | $28.57 footnote F3 | $225K | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 53,091 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 13,398 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 15,629 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 23,442 | $0.00 | - | |
| ||||||
| Susan Bobulsky - Officer | Open-market sale | Common Stock | 1,195 | $27.00 | $32K | |
 Katey Einterz Owen - Director | Gift | Common Stock | 12,539 | - footnote F1 | - | |
| ||||||
| Katey Einterz Owen - Director | Open-market sale | Common Stock | 9,615 | $26.00 | $250K | |
 Robert Hershberg - Director | Option exercise | Common Stock | 15,000 | $6.32 | $95K | |
| Robert Hershberg - Director | Open-market sale | Common Stock | 15,000 | $24.39 footnote F1 | $366K | |
| Robert Hershberg - Director | Open-market sale | Common Stock | 15,664 | $24.41 footnote F2 | $382K | |
| Robert Hershberg - Director | Option exercise | Stock Option (right to buy) | 15,000 | $0.00 | - | |
| ||||||
| Chad M. Robins - Officer | Option exercise | Common Stock | 321,324 | $6.55 | $2.10M | |
| Chad M. Robins - Officer | Open-market sale | Common Stock | 318,799 | $25.08 footnote F1 | $8.00M | |
| Chad M. Robins - Officer | Open-market sale | Common Stock | 2,525 | $25.57 footnote F2 | $65K | |
| Chad M. Robins - Officer | Option exercise | Common Stock | 278,676 | $6.55 | $1.83M | |
| Chad M. Robins - Officer | Open-market sale | Common Stock | 278,472 | $24.48 footnote F3 | $6.82M | |
| Chad M. Robins - Officer | Open-market sale | Common Stock | 204 | $25.14 footnote F4 | $5K | |
| Chad M. Robins - Officer | Option exercise | Stock Option (right to buy) | 321,324 | $0.00 | - | |
| Chad M. Robins - Officer | Option exercise | Stock Option (right to buy) | 278,676 | $0.00 | - | |
| ||||||
 Peter M. Neupert - Director | Option exercise | Common Stock | 15,000 | $6.32 | $95K | |
| Peter M. Neupert - Director | Open-market sale | Common Stock | 15,000 | $25.23 footnote F1 | $378K | |
| Peter M. Neupert - Director | Open-market sale | Common Stock | 40,000 | $25.10 footnote F2 | $1.00M | |
| Peter M. Neupert - Director | Open-market sale | Common Stock | 69,690 | $25.16 footnote F3 | $1.75M | |
| Peter M. Neupert - Director | Option exercise | Stock Option (right to buy) | 15,000 | $0.00 | - | |
| ||||||
| Susan Bobulsky - Officer | Open-market sale | Common Stock | 3,000 | $25.00 | $75K | |
| Susan Bobulsky - Officer | Open-market sale | Common Stock | 1,299 | $24.00 | $31K | |
| Harlan S. Robins - Officer | Option exercise | Common Stock | 284,800 | $6.55 | $1.87M | |
| Harlan S. Robins - Officer | Open-market sale | Common Stock | 278,698 | $21.72 footnote F2 | $6.05M | |
| Harlan S. Robins - Officer | Open-market sale | Common Stock | 213,702 | $22.12 footnote F3 | $4.73M | |
| Harlan S. Robins - Officer | Option exercise | Stock Option (right to buy) | 284,800 | $0.00 | - | |
| ||||||
| Susan Bobulsky - Officer | Open-market sale | Common Stock | 5,000 | $23.00 | $115K | |
| Francis Lo - Officer | Option exercise | Common Stock | 59,374 | $7.80 | $463K | |
| Francis Lo - Officer | Option exercise | Common Stock | 23,677 | $12.14 | $287K | |
| Francis Lo - Officer | Option exercise | Common Stock | 22,711 | $8.46 | $192K | |
| Francis Lo - Officer | Open-market sale | Common Stock | 105,762 | $22.59 footnote F2 | $2.39M | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 59,374 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 23,677 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 22,711 | $0.00 | - | |
| ||||||
| Harlan S. Robins - Officer | Open-market sale | Common Stock | 239,351 | $21.74 footnote F2 | $5.20M | |
| Harlan S. Robins - Officer | Open-market sale | Common Stock | 146,889 | $22.45 footnote F3 | $3.30M | |
| ||||||
| Francis Lo - Officer | Option exercise | Common Stock | 3,500 | $7.80 | $27K | |
| Francis Lo - Officer | Option exercise | Common Stock | 3,300 | $12.14 | $40K | |
| Francis Lo - Officer | Option exercise | Common Stock | 12,206 | $8.46 | $103K | |
| Francis Lo - Officer | Option exercise | Common Stock | 4,688 | $3.99 | $19K | |
| Francis Lo - Officer | Option exercise | Common Stock | 14,064 | $8.12 | $114K | |
| Francis Lo - Officer | Open-market sale | Common Stock | 8,743 | $22.18 footnote F2 | $194K | |
| Francis Lo - Officer | Open-market sale | Common Stock | 42,261 | $22.50 footnote F3 | $951K | |
| Francis Lo - Officer | Option exercise | Common Stock | 12,626 | $7.80 | $98K | |
| Francis Lo - Officer | Option exercise | Common Stock | 12,600 | $12.14 | $153K | |
| Francis Lo - Officer | Option exercise | Common Stock | 12,637 | $8.46 | $107K | |
| Francis Lo - Officer | Open-market sale | Common Stock | 44,838 | $22.59 footnote F4 | $1.01M | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 3,500 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 3,300 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 12,206 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 4,688 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 14,064 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 12,626 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 12,600 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 12,637 | $0.00 | - | |
| ||||||
| Susan Bobulsky - Officer | Open-market sale | Common Stock | 487 | $22.00 | $11K | |
| Sharon Benzeno - Officer | Option exercise | Stock Option (right to buy) | 11,034 | $0.00 | - | |
| Sharon Benzeno - Officer | Option exercise | Stock Option (right to buy) | 1,837 | $0.00 | - | |
| Sharon Benzeno - Officer | Option exercise | Stock Option (right to buy) | 24,944 | $0.00 | - | |
| Sharon Benzeno - Officer | Option exercise | Stock Option (right to buy) | 24,944 | $0.00 | - | |
| Sharon Benzeno - Officer | Option exercise | Stock Option (right to buy) | 51,570 | $0.00 | - | |
| Sharon Benzeno - Officer | Option exercise | Common Stock | 11,034 | $12.14 | $134K | |
| Sharon Benzeno - Officer | Open-market sale | Common Stock | 11,034 | $21.00 footnote F2 | $232K | |
| Sharon Benzeno - Officer | Option exercise | Common Stock | 1,837 | $12.14 | $22K | |
| Sharon Benzeno - Officer | Option exercise | Common Stock | 24,944 | $8.46 | $211K | |
| Sharon Benzeno - Officer | Option exercise | Common Stock | 24,944 | $3.99 | $100K | |
| Sharon Benzeno - Officer | Option exercise | Common Stock | 51,570 | $8.12 | $419K | |
| Sharon Benzeno - Officer | Open-market sale | Common Stock | 154,768 | $21.14 footnote F3 | $3.27M | |
| ||||||
| Susan Bobulsky - Officer | Open-market sale | Common Stock | 5,000 | $20.50 | $103K | |
 Michelle Renee Griffin - Director | Option exercise | Stock Option (right to buy) | 52,084 | $0.00 | - | |
| Michelle Renee Griffin - Director | Option exercise | Common Stock | 52,084 | $7.80 | $406K | |
| Michelle Renee Griffin - Director | Open-market sale | Common Stock | 52,084 | $20.18 footnote F2 | $1.05M | |
| ||||||
| Harlan S. Robins - Officer | Open-market sale | Common Stock | 100,000 | $17.37 footnote F2 | $1.74M | |
| Harlan S. Robins - Officer | Open-market sale | Common Stock | 6,160 | $18.01 footnote F3 | $111K | |
| ||||||
| Susan Bobulsky - Officer | Open-market sale | Common Stock | 5,000 | $19.00 | $95K | |
| Francis Lo - Officer | Option exercise | Common Stock | 5,792 | $12.14 | $70K | |
| Francis Lo - Officer | Option exercise | Common Stock | 2,009 | $8.46 | $17K | |
| Francis Lo - Officer | Option exercise | Common Stock | 2,344 | $3.99 | $9K | |
| Francis Lo - Officer | Option exercise | Common Stock | 9,376 | $8.12 | $76K | |
| Francis Lo - Officer | Open-market sale | Common Stock | 39,741 | $17.49 | $695K | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 5,792 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 2,009 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 2,344 | $0.00 | - | |
| Francis Lo - Officer | Option exercise | Stock Option (right to buy) | 9,376 | $0.00 | - | |
| Susan Bobulsky - Officer | Open-market sale | Common Stock | 11,000 | $18.00 | $198K | |
| Kyle Piskel - Officer | Open-market sale | Common Stock | 3,115 | $13.04 | $41K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,707 | $8.46 | $124K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,037 | $14.23 footnote F2 | $271K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,707 | $0.00 | - | |
| ||||||
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $8.46 | $125K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $14.13 footnote F2 | $269K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $8.46 | $125K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $13.74 footnote F3 | $262K | |
| Julie Rubinstein - Officer | Option exercise | Common Stock | 14,722 | $8.46 | $125K | |
| Julie Rubinstein - Officer | Open-market sale | Common Stock | 19,060 | $14.02 footnote F4 | $267K | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| Julie Rubinstein - Officer | Option exercise | Stock Option (right to buy) | 14,722 | $0.00 | - | |
| ||||||
Item 2.02, 5.02, 9.01
Item 1.01, 1.02, 2.03, 3.02, 8.01, 9.01
Item 8.01, 9.01
Item 5.07
Recent ADPT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| SUSAN BOBULSKY | Officer | 6,444 | $192K | View on EDGAR | |
| JULIE RUBINSTEIN | Officer | 379,777 |
ADPT insider trading FAQ
What is the latest insider trade for ADPT?
Adaptive Biotechnologies Corp (ADPT) had 17 insider filings in the last 90 days, with the most recent on 2026-10-13. The full record for ADPT runs to 81 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ADPT stock?
No insider purchases of ADPT were filed in the last 90 days.
How many insiders are selling ADPT stock?
37 insider sales of ADPT were filed in the last 90 days, totaling $39.51M.
Where can I see ADPT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ADPT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Julie Rubinstein view on EDGAR
- - Julie Rubinstein view on EDGAR
- - Susan Bobulsky view on EDGAR
- - Julie Rubinstein view on EDGAR
- - Francis Lo view on EDGAR
- - Francis Lo view on EDGAR
- - Susan Bobulsky view on EDGAR
- - Katey Einterz Owen view on EDGAR
- - Katey Einterz Owen view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ADPT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ADPT with a 7-day demo
- ADPT on your watchlist
- Every ADPT Form 4 filing on record
- Up to 3 months of ADPT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
